S. Lloyd

发表

Sex Effects in Mouse Prion Disease Incubation Time

J. Collinge, S. Brandner, S. Akhtar, 2011, PloS one.

Identification and characterization of a novel mouse prion gene allele

J. Collinge, J. Linehan, S. Brandner, 2004, Mammalian Genome.

Isolation and partial characterization of a chloride channel gene which is expressed in kidney and is a candidate for Dent's disease (an X-linked hereditary nephrolithiasis).

E. Hatchwell, S. Fisher, I. Craig, 1994, Human molecular genetics.

Characterization of two distinct prion strains derived from bovine spongiform encephalopathy transmissions to inbred mice.

J. Collinge, S. Joiner, J. Linehan, 2004, The Journal of general virology.

Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13.

R. Thakker, M. Whyte, P. Dixon, 1999, American journal of human genetics.

Isolated hypercalciuria with mutation in CLCN5: relevance to idiopathic hypercalciuria.

S. Pearce, R. Thakker, C. Langman, 2000, Kidney international.

Human Prion Protein with Valine 129 Prevents Expression of Variant CJD Phenotype

J. Collinge, A. Hill, S. Joiner, 2004, Science.

Genetic Factors in Mammalian Prion Diseases.

J. Collinge, S. Mead, S. Lloyd, 2019, Annual review of genetics.

Haemophilia care in Zimbabwe.

L. Levy, A. Coutts, J. Adewuyi, 1996, The Central African journal of medicine.

Haemophilia in Zimbabwe.

J. Mukiibi, B. Paul, S. Lloyd, 1990, Tropical and geographical medicine.

A common molecular basis for three inherited kidney stone diseases

M. Devoto, B. Harding, S. Fisher, 1996, Nature.

Characterization of mutations in patients with multiple endocrine neoplasia type 1.

S. Forbes, B. Harding, C. Edwards, 1998, American journal of human genetics.

Genetics of prion disease.

J. Collinge, S. Mead, S. Lloyd, 2011, Topics in current chemistry.

Genetic mapping studies of 40 loci and 23 cosmids in chromosome 11p13-11g13, and exclusion of μ-calpain as the multiple endocrine neoplasia type 1 gene

B. Harding, R. Thakker, M. Pook, 1996, Human Genetics.

Exclusion of ZFM1 as a candidate gene for multiple endocrine neoplasia type 1 (MEN1)

S. Pearce, R. Thakker, S. Leigh, 1997, Human Genetics.

Investigation of Mcp1 as a Quantitative Trait Gene for Prion Disease Incubation Time in Mouse

J. Collinge, J. Linehan, S. Brandner, 2008, Genetics.

Mutations of CLCN5 in Japanese children with idiopathic low molecular weight proteinuria, hypercalciuria and nephrocalcinosis.

R. Thakker, T. Igarashi, T. Matsuyama, 1997, Kidney international.

Cloning and characterization of CLCN5, the human kidney chloride channel gene implicated in Dent disease (an X-linked hereditary nephrolithiasis).

S. Fisher, I. Craig, S. Pearce, 1995, Genomics.

Idiopathic low molecular weight proteinuria associated with hypercalciuric nephrocalcinosis in Japanese children is due to mutations of the renal chloride channel (CLCN5).

S. Pearce, R. Thakker, T. Jentsch, 1997, The Journal of clinical investigation.

The Retinoic Acid Receptor Beta (Rarb) Region of Mmu14 Is Associated with Prion Disease Incubation Time in Mouse

J. Collinge, S. Akhtar, S. Lloyd, 2010, PloS one.

HECTD2 Is Associated with Susceptibility to Mouse and Human Prion Disease

M. Alpers, J. Collinge, H. Hummerich, 2009, PLoS genetics.

Identification of genetic loci affecting mouse-adapted bovine spongiform encephalopathy incubation time in mice

J. Collinge, E. Fisher, J. Uphill, 2002, Neurogenetics.

Identification of multiple quantitative trait loci linked to prion disease incubation period in mice

E. Fisher, M. Farrall, J. Collinge, 2001, Proceedings of the National Academy of Sciences of the United States of America.

BSE prions propagate as either variant CJD‐like or sporadic CJD‐like prion strains in transgenic mice expressing human prion protein

J. Collinge, A. Hill, S. Joiner, 2002, The EMBO journal.

Genetics of prion diseases

J. Collinge, S. Mead, S. Lloyd, 2013, Current opinion in genetics & development.

Microglial Cx3cr1 knockout reduces prion disease incubation time in mice

J. Collinge, S. Brandner, S. Akhtar, 2014, BMC Neuroscience.

Rare structural genetic variation in human prion diseases

S. Mead, J. Collinge, I. Zerr, 2015, Neurobiology of Aging.

Sod1 Deficiency Reduces Incubation Time in Mouse Models of Prion Disease

J. Collinge, H. Hummerich, S. Brandner, 2013, PloS one.

Overexpression of the Hspa13 (Stch) gene reduces prion disease incubation time in mice

J. Collinge, Andrew Tomlinson, H. Hummerich, 2012, Proceedings of the National Academy of Sciences.

A Copine family member, Cpne8, is a candidate quantitative trait gene for prion disease incubation time in mouse

J. Collinge, H. Hummerich, S. Lloyd, 2009, neurogenetics.

Shadoo (Sprn) and prion disease incubation time in mice

J. Collinge, H. Pota, S. Lloyd, 2009, Mammalian Genome.

Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders.

S. Fisher, I. Craig, S. Pearce, 1997, Human molecular genetics.

In vitro screen of prion disease susceptibility genes using the scrapie cell assay

J. Collinge, H. Hummerich, P. Klöhn, 2014, Human molecular genetics.

Microglial Cx3cr1knockout reduces prion disease incubation time in mice

J. Collinge, S. Brandner, S. Lloyd, 2014, BMC Neuroscience.

HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q

Nick C Fox, M. Rossor, S. Mead, 2009, BMC Medical Genetics.

Familial benign hypercalcaemia, Oklahoma variant (FBHok): Localisation to chromosome 19q13.

R. Thakker, M. Whyte, S. Lloyd, 1997 .

Rare structural genetic variation in human prion diseases.

S. Mead, J. Collinge, I. Zerr, 2015, Neurobiology of aging.

A familial syndrome due to Arg648Stop mutation in the X-linked renal chloride channel gene

R. Thakker, M. Bianchi, M. Bosio, 1999, Pediatric Nephrology.

Folate to the rescue

S. Lloyd, 2000 .

HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q

Nick C Fox, M. Rossor, S. Mead, 2009, BMC Medical Genetics.